SNGX News and Press, Soligenix Inc. From 03/19/20

Nano cap Soligenix (NASDAQ: SNGX ) jumps  16%  premarket on light volume in reaction to preliminary topline results from a Phase 3 clinical trial, FLASH , evaluating SGX301 (synthetic hypericin) in patients with cutaneous T-cell lymphoma (CTCL). More news on: Soligenix, Inc., ...

PRINCETON, N.J. , March 19, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today positive ...

PRINCETON, N.J. , Feb. 27, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its ongoin...

Miami Beach, Florida--(Newsfile Corp. - February 20, 2020) - Soligenix may be nearing a transformative point in its history as data from its Phase 3 SGX301 (FLASH) trial to treat cutaneous T-cell lymphoma (CTCL) nears its release. The topline data from this late-stage study is expected in less...

Are These The Best Stocks To Trade Before The End Of February 2020? It goes without saying that investing in penny stocks comes with a certain level of risk. But at the same time, these cheap stocks can often generate substantial returns in a short period of time. Over the years, plenty of...

The following slide deck was published by Soligenix, Inc. in conjunction with this Read more ...

CounterPath (NASDAQ: CPAH ) +49%  on securing five-year deal with Vodafone Fiji to extend superior quality voice services to consumers. More news on: CounterPath Corporation, Alpha Pro Tech, Ltd., NanoViricides, Inc., Stocks on the move, , Read more ...

The FDA designates Soligenix's (NASDAQ: SNGX ) RiVax (heat stable ricin toxin vaccine) for Fast Track review for the prevention of ricin intoxication. More news on: Soligenix, Inc., Healthcare stocks news, Stocks on the move, Read more ...

PRINCETON, N.J. , Feb. 13, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its RiVax ...

PRINCETON, N.J. , Feb. 11, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that ...